Browse by Aston Author

Rana, K.; Hill, E.J.; Bailey, C.J.; Bellary, S. and Brown, J.E. Association between body composition, circulating irisin and telomere length in healthy individuals and individuals with Type 2 diabetes. Diabetic Medicine, 31 (s1), p. 38.

Woehrling, E.K.; Hill, E.J. and Coleman, M.D. Development of a neurotoxicity test-system, using human post-mitotic, astrocytic and neuronal cell lines in co-culture. Toxicology in Vitro, 21 (7), pp. 1241-1246.

Nagel, D.A.; Hill, E.J. and Coleman, M.D. In vitro chronic neurotoxicity assays:present and future developments. IN: Medical biotechnology and healthcare. Moo-Young, Murray (ed.) Academic Press.

Dias, I.K.I.; Mistry, J.; Tarzyluck, M.; Hill, E.J.; Bennett, S.J.; Polidori, M.C.; Lip, G.Y.H. and Griffiths, H.R. Oxidised LDL-lipids alter redox ratio, lipid raft formation and increase amyloid beta production by SHSY-5Y cells. Experimental Gerontology, 48 (7), p. 688.

Choudry, N.; Robinson, J.; Arif, M.; Rana, K.S.; Hill, E.J.; Turner, S.; Bailey, C.J. and Brown, J.E. Phytoestrogen-ind uced glucose uptake and cellular proliferation in L6 myotubesadipocyte function. Diabetic Medicine, 30 (S1), p. 39.

Rana, K.S.; Hill, E.J.; Bellary, S. and Brown, J.E. The effect of the senescence-associated secretory phenotype (SASP) on glucose homeostasis in metabolic cells. Diabetic Medicine, 32 (Suppl.), pp. 93-94.